This is a study to assess the distribution, metabolism and excretion of [14C]AZD6765 after a single-dose intravenous administration.

Inclusion Criteria:

• Subjects must have a normal creatinine clearance of ≥60 mL/min
• Subjects who self-identify their race as Asian

Exclusion Criteria:

• History of any clinically significant medical, neurologic or psychiatric disease as judged by the investigator
• History of symptomatic orthostatic hypotension (ie, postural syncope)
• Subjects who have received any radiolabelled study drug within 12 months of the Screening Visit.
• Subjects who are monitored for radioactivity as part of their occupation
• Subjects who have been exposed to radiation levels above background, (eg, throughX-Ray examinations) of >5mSv in the last year, >10 mSv over the last 5 years or a cumulative total of >1mSv per year of life.